Preconditioning with thyroid hormone (3,5,3-triiodothyronine) prevents renal ischemia-reperfusion injury in mice

Surgery. 2014 Mar;155(3):554-61. doi: 10.1016/j.surg.2013.10.005. Epub 2013 Oct 11.

Abstract

Background: 3,5,3-triiodothyronine (T3) was found to decrease ischemia-reperfusion (I/R) injury of liver and myocardium in animal models when preconditioned 48 hours in advance of the I/R injury. The purpose of this study was to evaluate the effects of T3 preconditioning on renal I/R injury with different time intervals and to determine the changes in antioxidants, apoptosis, and nitric oxide synthase (NOS) in each condition.

Methods: In male C57BL/6 mice, renal I/R injury was induced by temporary ligation of the bilateral renal pedicles for 45 minutes followed by a reperfusion period for 24 hours. Preconditioning with intraperitoneal injection of T3 was performed 24 or 6 hours before or at the time of I/R injury.

Results: From the histologic examination, tubular injury was decreased in mice preconditioned with T3 6 hours before I/R injury. The levels of proinflammatory cytokines were decreased with T3 preconditioning, either 6 hours or at the time of I/R injury. The levels of glutathione were increased in all treatment groups. Expressions of neuronal NOS were increased when preconditioned 6 hours before or at the time of I/R injury. The number of apoptotic tubular epithelial cell evaluated by terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling assay was decreased when preconditioned immediately before I/R injury.

Conclusion: Preconditioning with T3 6 hours or immediately before I/R injury had a protective effect on renal I/R injury. The changes of NOS and antiapoptosis, other than well-known antioxidative properties, may play a role in the effect of short-term preconditioning.

Publication types

  • Evaluation Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antioxidants / metabolism
  • Apoptosis
  • Biomarkers / metabolism
  • Cytokines / metabolism
  • Drug Administration Schedule
  • In Situ Nick-End Labeling
  • Injections, Intraperitoneal
  • Ischemic Preconditioning / methods*
  • Kidney / blood supply*
  • Kidney / metabolism
  • Kidney / pathology
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Protective Agents / therapeutic use*
  • Real-Time Polymerase Chain Reaction
  • Reperfusion Injury / prevention & control*
  • Treatment Outcome
  • Triiodothyronine / therapeutic use*

Substances

  • Antioxidants
  • Biomarkers
  • Cytokines
  • Protective Agents
  • Triiodothyronine